UC San Francisco study finds azithromycin in Sub-Saharan Africa children aged 5 and under could reduce child mortality by 14%.

A UC San Francisco study suggests that treating children aged 5 and under in Sub-Saharan Africa with azithromycin, a common antibiotic, could reduce child mortality by 14%. The previous WHO recommendation only included infants between 1-11 months old due to antibiotic resistance concerns. The study found that treating older children benefits the younger, more vulnerable ones, as older siblings help transmit infections. The findings were published in the New England Journal of Medicine.

August 21, 2024
9 Articles